Quinethazone
From Self-sufficiency
| File:Quinethazone.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
7-chloro-2-ethyl-4-oxo-1,2,3,4-tetrahydroquinazoline- 6-sulfonamide | |
| Clinical data | |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | 73-49-4 |
| ATC code | C03BA02 (WHO) |
| PubChem | CID 6307 |
| Chemical data | |
| Formula | C10H12ClN3O3S |
| Molar mass | 289.739 g/mol[[Script error: No such module "String".]] |
| (verify) | |
Quinethazone (INN, brand name Hydromox) is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.
Synthesis
References
Cohen, Elliott; Klarberg, Betty; Vaughan, James R. (1960). Journal of the American Chemical Society. 82: 2731. doi:10.1021/ja01496a020. Missing or empty |title= (help)
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Pages with citations lacking titles
- 2Fix
- Thiazides
- Quinazolines
- Lactams
- Organochlorides
- Cardiovascular system drug stubs
